In recent months, the X account of the Venezuelan media outlet Polianalítica, followed by over 63,000 users, published a series of posts portraying Beijing as a steadfast political and security backer ...

A new presidential initiative called QMIT will advance the development of quantum technologies—and help ensure that they are used for good. As MIT navigates a difficult and constantly changing higher ...

Longtime Black Sabbath guitarist Tony Iommi has some big 2026 news to share as he reflected on all the big happenings in his world over the last 12 months for his New Year video message. The guitar ...

A trio of large observational studies reported at the San Antonio Breast Cancer Symposium (SABCS) 2025 suggest that GLP-1 receptor agonists may improve outcomes in some women with breast cancer. Two ...

When Chase Johnson was 31, her dog began acting strange. He was anxious, wouldn’t leave her side and, one day, pushed his nose into the side of her breast. Johnson felt a hard lump. “I wasn’t someone ...

NCT’s Doyoung has released his new solo single album “Promise,” along with the music video for its title track! Check out Doyoung’s new music video for “Promise” below: On December 1 at midnight KST, ...

Despite the considerable disease burden associated with hereditary hemorrhagic telangiectasia, no therapies are licensed for treatment. In a proof-of-concept, placebo-controlled trial, the ...

It is tempting to regard AI as a panacea for addressing our most urgent global challenges, from climate change to resource scarcity. Yet the truth is more complex: unless we pair innovation with ...

The semiconductor industry is increasingly turning to artificial intelligence as the solution for increasing complexity in test analytics, hoping algorithms can tame the growing flood of production ...

Everything in Japan has a mascot. Towns, sports, corporations, train stations—even prisons have mascots themed around local delicacies. In Promise Mascot Agency, those mascots aren't just people ...

Eli Lilly said on Thursday it will start late-stage trials of its experimental obesity drug next month after it helped patients lose as much as 20.1% of their weight in a mid-stage trial. The ...